Scott S - Search Results

1

Evidence that pioglitazone, metformin and pentoxifylline are inhibitors of glycation.

Rahbar S, Natarajan R, Yerneni K, Scott S, Gonzales N, Nadler JL. Rahbar S, et al. Among authors: scott s. Clin Chim Acta. 2000 Nov;301(1-2):65-77. doi: 10.1016/s0009-8981(00)00327-2. Clin Chim Acta. 2000. PMID: 11020463

2

Evidence that pioglitazone increases intracellular free magnesium concentration in freshly isolated rat adipocytes.

Nadler J, Scott S. Nadler J, et al. Among authors: scott s. Biochem Biophys Res Commun. 1994 Jul 15;202(1):416-21. doi: 10.1006/bbrc.1994.1944. Biochem Biophys Res Commun. 1994. PMID: 8037742

3

Novel inhibitors of advanced glycation endproducts.

Rahbar S, Kumar Yernini K, Scott S, Gonzales N, Lalezari I. Rahbar S, et al. Among authors: scott s. Biochem Biophys Res Commun. 1999 Sep 7;262(3):651-6. doi: 10.1006/bbrc.1999.1275. Biochem Biophys Res Commun. 1999. PMID: 10471380

4

Novel inhibitors of advanced glycation endproducts (part II).

Rahbar S, Yerneni KK, Scott S, Gonzales N, Lalezari I. Rahbar S, et al. Among authors: scott s. Mol Cell Biol Res Commun. 2000 Jun;3(6):360-6. doi: 10.1006/mcbr.2000.0239. Mol Cell Biol Res Commun. 2000. PMID: 11032758

5

Prevention of early renal disease, dyslipidaemia and lipid peroxidation in STZ-diabetic rats by LR-9 and LR-74, novel AGE inhibitors.

Figarola JL, Scott S, Loera S, Xi B, Synold T, Weiss L, Rahbar S. Figarola JL, et al. Among authors: scott s. Diabetes Metab Res Rev. 2005 Nov-Dec;21(6):533-44. doi: 10.1002/dmrr.550. Diabetes Metab Res Rev. 2005. PMID: 15818713

6

Mechanisms of ANG II-induced mitogenic responses: role of 12-lipoxygenase and biphasic MAP kinase.

Wen Y, Nadler JL, Gonzales N, Scott S, Clauser E, Natarajan R. Wen Y, et al. Among authors: scott s. Am J Physiol. 1996 Oct;271(4 Pt 1):C1212-20. doi: 10.1152/ajpcell.1996.271.4.C1212. Am J Physiol. 1996. PMID: 8897827

7

Evidence that angiotensin II and lipoxygenase products activate c-Jun NH2-terminal kinase.

Wen Y, Scott S, Liu Y, Gonzales N, Nadler JL. Wen Y, et al. Among authors: scott s. Circ Res. 1997 Nov;81(5):651-5. doi: 10.1161/01.res.81.5.651. Circ Res. 1997. PMID: 9351437

8

Angiotensin II signaling in vascular smooth muscle cells under high glucose conditions.

Natarajan R, Scott S, Bai W, Yerneni KK, Nadler J. Natarajan R, et al. Among authors: scott s. Hypertension. 1999 Jan;33(1 Pt 2):378-84. doi: 10.1161/01.hyp.33.1.378. Hypertension. 1999. PMID: 9931133

9

LR-90 a new advanced glycation endproduct inhibitor prevents progression of diabetic nephropathy in streptozotocin-diabetic rats.

Figarola JL, Scott S, Loera S, Tessler C, Chu P, Weiss L, Hardy J, Rahbar S. Figarola JL, et al. Among authors: scott s. Diabetologia. 2003 Aug;46(8):1140-52. doi: 10.1007/s00125-003-1162-0. Epub 2003 Jul 5. Diabetologia. 2003. PMID: 12845431

10

Renoprotective and lipid-lowering effects of LR compounds, novel advanced glycation end product inhibitors, in streptozotocin-induced diabetic rats.

Figarola JL, Scott S, Loera S, Xi B, Synold T, Rahbar S. Figarola JL, et al. Among authors: scott s. Ann N Y Acad Sci. 2005 Jun;1043:767-76. doi: 10.1196/annals.1333.089. Ann N Y Acad Sci. 2005. PMID: 16037304

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,889 results

Search Page

Filters